Evidence mapPaperPMID 40539193Full record

ReviewCureus2025

From Research to Practice: The Future of Cardiovascular Care.

Prabhash C Manoria

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Prabhash C ManoriaCardiology, Director of Manoria Heart and Critical Care Hospital, Bhopal, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, necessitating continuous advancements in research and clinical practice. Research advancements have significantly transformed our understanding and management of CVDs. Recent breakthroughs in genomics, artificial intelligence (AI), wearable technology, and regenerative medicine are reshaping cardiovascular (CV) care. This review explores key innovations that bridge the gap between research and clinical application, emphasizing precision medicine, early detection, and personalized therapies. We also discuss challenges in implementation and future directions for optimizing CV outcomes.

Indexed as

artificial intelligencecardiovascular diseasegenomicsstem cellswearables

Identifiers

PMID40539193
PMCPMC12178272

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.